s6y Dyne Therapeutics, Inc. S-8

Dyne Therapeutics, Inc. S-8, filed Mar 10, 2022: EX-23.1

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated March 10, 2022, relating to the financial statements of Dyne Therapeutics, Inc. appearing in the Annual Report on Form 10-K of Dyne Therapeutics, Inc. for the year ended December 31, 2021.

 

/s/ Deloitte & Touche LLP

 

 

 

Boston, Massachusetts

 

March 10, 2022